• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Conference Coverage
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Resources
CBD in Pets
CE Requirements by State
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Toxoplasma Re-shedding Rates in Domestic Cats

February 28, 2018
Natalie Stilwell, DVM, MS, PhD

Study shows that infection offers cross-protection against multiple strains of Toxoplasma gondii.

Toxoplasmosis is a common parasitic disease found in a wide range of species, including humans. As the only known definitive hosts for Toxoplasma gondii, felids typically infect other hosts by shedding T gondii oocysts in feces.

Existing literature suggests that cats experience temporary immunity against re-shedding of oocysts upon reinfection with T gondii and that oocyst shedding is quantitatively lower after subsequent infections. Researchers in Brazil, a location known for high genetic diversity of Toxoplasma, recently explored the effect of multiple strains of T gondii on oocyst re-shedding up to 36 months after initial infection. Their findings were presented in Veterinary Parasitology.

Analysis

Thirteen domestic short-haired cats aged 3 to 6 months were chosen for the study based on negative T gondii serum titer on indirect immunofluorescence assay and negative fecal examination results. While anesthetized, the cats were inoculated orally via stomach tube with approximately 800 T gondii cysts isolated from the brain tissue of challenged mice. Inoculations were performed at 3 time points with strains belonging to the 2 most common genotypes implicated in human and animal toxoplasmosis cases.

Five cats were inoculated initially with a genotype II strain and re-infected at 12 months with the genotype III strain. Another group of 5 cats was infected with genotype II strains at 0 and 12 months, followed by re-infection with a genotype III strain at 36 months. The final group consisted of 3 cats initially inoculated with a genotype II strain and re-infected at 36 months with a genotype III strain.

Fecal samples, which were collected daily for the first 20 days after each inoculation, were used to calculate the total oocysts per gram of feces (OOPG) count for each cat. IgG, IgM, and IgA levels were measured in serum samples via enzyme-linked immunosorbent assay (ELISA) to determine antibody response.

Results

Advertisement

Among the 13 inoculated cats, the mean prepatent period after initial T gondii infection was 3.4 days and oocyst shedding lasted an average of 7.0 days. Peak shedding occurred, on average, 6.9 days after inoculation. All cats shed similar amounts of oocysts after primary inoculation regardless of T gondii strain and genotype, while only 1 of 10 cats shed oocysts after the 12-month re-infection and 5 of 7 cats shed oocysts after the 36-month re-infection.

Average OOPG for cats that shed oocysts was lower after the 12-month (118,500) and 36-month (179,000) re-infections compared with after initial infection (749,141). The average prepatent period during re-infection was slightly increased and shedding duration decreased by more than 50% compared with initial infection.

Serum IgM, IgA, and IgG were all measurable from just after the first infection shedding period until 3 months after the 12- and 36-month re-infections, indicating long-term antibody response. Interestingly, re-infection did not significantly change antibody concentrations.

Conclusion

T gondii infection provided temporary protection against re-shedding of multiple strains of oocysts, although protection appeared to decline between 1 and 3 years after infection.

Dr. Stilwell received her DVM from Auburn University, followed by a MS in Fisheries and Aquatic Sciences and a PhD in Veterinary Medical Sciences from the University of Florida. She provides freelance medical writing and aquatic veterinary consulting services through her business, Seastar Communications and Consulting.

Related Content:

Parasitology
Expert shares pet care tips for springtime
Expert shares pet care tips for springtime
AHS urges veterinarians to submit data for 2022 Heartworm Incidence Map
AHS urges veterinarians to submit data for 2022 Heartworm Incidence Map
Top dvm360 podcasts of 2022: #3
Top dvm360 podcasts of 2022: #3

Advertisement

Latest News

Xylazine moves from the stables to the streets

DEA reports widespread threat of fentanyl mixed with xylazine

3 Must-reads for National Poison Prevention Week

UC Davis study on eye diseases in kittens

View More Latest News
Advertisement